CYTARABINE PLUS IDARUBICIN OR DAUNORUBICIN AS INDUCTION AND CONSOLIDATION THERAPY FOR PREVIOUSLY UNTREATED ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA

被引:1
|
作者
WIERNIK, PH
BANKS, PLC
CASE, DC
ARLIN, ZA
PERIMAN, PO
TODD, MB
RITCH, PS
ENCK, RE
WEITBERG, AB
机构
[1] ADRIA LABS INC, COLUMBUS, OH USA
[2] MAINE MED CTR, PORTLAND, ME 04102 USA
[3] NEW YORK MED COLL, VALHALLA, NY 10595 USA
[4] HARRINGTON CANC CTR, AMARILLO, TX USA
[5] YALE UNIV, SCH MED, NEW HAVEN, CT 06510 USA
[6] MED COLL WISCONSIN, MILWAUKEE, WI 53226 USA
[7] RIVERSIDE CANC INST, COLUMBUS, OH USA
[8] ROGER WILLIAMS GEN HOSP, PROVIDENCE, RI 02908 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [1] Mitoxantrone plus cytarabine versus daunorubicin plus cytarabine as induction therapy for previously untreated adult patients with acute myeloid leukemia
    Nikanfar, Alireza
    Asvadi, Iraj
    Vaez, Jalil
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2007, 23 (06) : 909 - 912
  • [2] MITOXANTRONE AND CYTARABINE VERSUS DAUNORUBICIN AND CYTARABINE IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    WAHLIN, A
    HORNSTEN, P
    HEDENUS, M
    MALM, C
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (06) : 480 - 483
  • [3] IDARUBICIN IN THE THERAPY OF ACUTE MYELOID-LEUKEMIA - FINAL ANALYSIS IN 57 PREVIOUSLY UNTREATED PATIENTS
    DELILIERS, GL
    ANNALORO, C
    ORIANI, A
    POZZOLI, E
    CORTELEZZI, A
    CORTELLARO, M
    MOZZANA, R
    DELLAVOLPE, A
    SOLIGO, D
    COFRANCESCO, E
    BOSCHETTI, C
    POLLI, EE
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (06) : 27 - 33
  • [4] CYTARABINE PLUS IDARUBICIN AS INDUCTION THERAPY FOR UNTREATED ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF 141 PATIENTS
    Leite, L.
    Nunes, M.
    Chacim, S.
    Ferreira, I.
    Moreira, C.
    Pereira, D.
    Brito, M.
    Viterbo, L.
    Martins, A.
    Moreira, I.
    Domingues, N.
    Espirito-Santo, A.
    Oliveira, I.
    Mariz, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 521 - 521
  • [5] A MULTICENTER TRIAL OF CYTARABINE PLUS IDARUBICIN OR DAUNORUBICIN AS INDUCTION THERAPY FOR ADULT NONLYMPHOCYTIC LEUKEMIA
    WIERNIK, PH
    CASE, DC
    PERIMAN, PO
    ARLIN, ZA
    WEITBERG, AB
    RITCH, PS
    TODD, MB
    [J]. SEMINARS IN ONCOLOGY, 1989, 16 (01) : 25 - 29
  • [6] A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia
    Masaoka, T
    Ogawa, M
    Yamada, K
    Kimura, K
    Ohashi, Y
    [J]. SEMINARS IN HEMATOLOGY, 1996, 33 (04) : 12 - 17
  • [7] CYTARABIN AND DAUNORUBICIN OR IDARUBICIN IN INDUCTION THERAPY OF ACUTE MYELOID LEUKEMIA PATIENTS
    Eivazi-Ziaei, Jamal
    Kermani, Iraj Asvadi
    Nikanfar, Alireza
    Maljaie, Hadi
    Mahmoudpour, Ali
    Dolatkhah, Roya
    Golchin, Mehri
    Vaez, Jalil
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2009, 25 (05) : 829 - 832
  • [8] A Phase 1 Study of Sequential Idarubicin plus Cytarabine, Followed by Lenalidomide, in Patients with Previously Untreated Acute Myeloid Leukemia (AML)
    Lancet, Jeffrey E.
    Komrokji, Rami S.
    Yu, Daohai
    Advani, Anjali S.
    Searles, Tammy
    Sekeres, Mikkael A.
    List, Alan F.
    [J]. BLOOD, 2011, 118 (21) : 1115 - 1116
  • [9] HIGH-DOSE CYTARABINE, IDARUBICIN, AND GRANULOCYTE-COLONY-STIMULATING FACTOR REMISSION INDUCTION THERAPY FOR PREVIOUSLY UNTREATED DE-NOVO AND SECONDARY ADULT ACUTE MYELOID-LEUKEMIA
    BAER, MR
    CHRISTIANSEN, NP
    FRANKEL, SR
    BRUNETTO, VL
    MROZEK, K
    BLOOMFIELD, CD
    HERZIG, GP
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (06) : 6 - 12
  • [10] Azacitidine Combined with Homoharringtonine, Idarubicin/Daunorubicin, Cytarabine for Previously Untreated Patients with Acute Myeloid Leukemia: A Single-Center, Phase 2 Study
    Li, Jun
    Huang, Yanqing
    Hou, Yue
    Zi, Jie
    Song, Chunhua
    Ge, Zheng
    [J]. BLOOD, 2022, 140 : 3273 - 3274